ATE53299T1 - Blutstillende irrigationsloesung. - Google Patents

Blutstillende irrigationsloesung.

Info

Publication number
ATE53299T1
ATE53299T1 AT86305933T AT86305933T ATE53299T1 AT E53299 T1 ATE53299 T1 AT E53299T1 AT 86305933 T AT86305933 T AT 86305933T AT 86305933 T AT86305933 T AT 86305933T AT E53299 T1 ATE53299 T1 AT E53299T1
Authority
AT
Austria
Prior art keywords
solution
hemostatic
irrigation solution
protamine
norepinephrine
Prior art date
Application number
AT86305933T
Other languages
English (en)
Inventor
Gerald M Lemole
Original Assignee
Gerald M Lemole
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gerald M Lemole filed Critical Gerald M Lemole
Application granted granted Critical
Publication of ATE53299T1 publication Critical patent/ATE53299T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482Serine endopeptidases (3.4.21)
    • A61K38/4833Thrombin (3.4.21.5)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT86305933T 1985-08-06 1986-08-01 Blutstillende irrigationsloesung. ATE53299T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/763,056 US4637815A (en) 1985-08-06 1985-08-06 Irrigational hemostatic solution
EP86305933A EP0211629B1 (de) 1985-08-06 1986-08-01 Blutstillende Irrigationslösung

Publications (1)

Publication Number Publication Date
ATE53299T1 true ATE53299T1 (de) 1990-06-15

Family

ID=25066769

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86305933T ATE53299T1 (de) 1985-08-06 1986-08-01 Blutstillende irrigationsloesung.

Country Status (5)

Country Link
US (1) US4637815A (de)
EP (1) EP0211629B1 (de)
JP (1) JPS6259222A (de)
AT (1) ATE53299T1 (de)
DE (1) DE3671700D1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5053006A (en) * 1988-04-19 1991-10-01 Watson Brant D Method for the permanent occlusion of arteries
EP0365705A1 (de) * 1988-10-26 1990-05-02 Zentralna Problemna Laboratoria Po Kryobiologia I Lyophilisazia Biopräparat zur Behandlung von Wunden
US5171217A (en) * 1991-02-28 1992-12-15 Indiana University Foundation Method for delivery of smooth muscle cell inhibitors
CA2175203A1 (en) * 1993-11-03 1995-05-11 Thaddeus P. Pruss Hemostatic patch
US5681278A (en) * 1994-06-23 1997-10-28 Cormedics Corp. Coronary vasculature treatment method
MX9703988A (es) * 1994-12-12 1998-02-28 Omeros Med Sys Inc SOLUCIaN Y MÉTODO DE IRRIGACIaN PARA LA INHIBICIaN DEL DOLOR, LA INFLAMACIaN Y ES ESPASMO.
KR100517210B1 (ko) * 1994-12-12 2006-06-07 오메로스 코포레이션 통증,염증및경련억제용관주용액
AU5638096A (en) * 1995-06-07 1996-12-30 Clarion Pharmaceuticals, Inc. Non-biological patch for hemostasis
BR9509985A (pt) * 1995-12-12 1998-11-03 Omeros Med Sys Inc Solução para irrigação e método para inibição de dor inflamação e esparmo
DE10258954A1 (de) * 2002-12-16 2004-07-08 Langer, Hans-Georg Blutungsstillende Wundversorgung
US20070053844A1 (en) * 2005-05-18 2007-03-08 Pulmatrix Inc. Formulations for alteration of biophysical properties of mucosal lining
CA2609456C (en) * 2005-05-25 2014-04-29 Massachusetts Institute Of Technology Localized delivery of cardiac inotropic agents
US8057426B2 (en) * 2007-01-03 2011-11-15 Medtronic Vascular, Inc. Devices and methods for injection of multiple-component therapies
CA2701555A1 (en) * 2007-10-02 2009-04-09 Hemostasis Holding Aps Systemic pro-hemostatic effect of sympathicomimetics with agonistic effects on .alpha.-adrenergic and/or .beta.-adrenergic receptors of the sympathetic nervous system, related to improved clot strength
WO2010027851A1 (en) * 2008-08-26 2010-03-11 Massachusetts Institute Of Technology Devices and systems for local delivery of inotropic agents to the epicardium
AU2010229668C1 (en) 2009-03-26 2016-09-15 Pulmatrix Operating Co., Inc. Dry powder formulations and methods for treating pulmonary diseases
HRP20120262T1 (hr) * 2009-03-26 2012-04-30 Pulmatrix Farmaceutske formulacije i postupci za liječenje infekcija dišnih puteva
US20130164338A1 (en) 2010-08-30 2013-06-27 Pulmatrix, Inc. Treatment of cystic fibrosis using calcium lactate, leucine and sodium chloride in a respiraple dry powder
WO2012030664A1 (en) 2010-08-30 2012-03-08 Pulmatrix, Inc. Dry powder formulations and methods for treating pulmonary diseases
WO2012044736A1 (en) 2010-09-29 2012-04-05 Pulmatrix, Inc. Monovalent metal cation dry powders for inhalation
PT3470057T (pt) 2010-09-29 2021-12-03 Pulmatrix Operating Co Inc Pós secos catiónicos compreendendo sais de magnésio
CA2865972C (en) 2012-02-29 2022-01-04 Pulmatrix, Inc. Inhalable dry powders
WO2014165303A1 (en) 2013-04-01 2014-10-09 Pulmatrix, Inc. Tiotropium dry powders
RU2741304C2 (ru) * 2015-11-08 2021-01-25 Омрикс Биофармасьютикалс Лтд. Гемостатическая композиция
US10137220B2 (en) 2015-11-08 2018-11-27 Omrix Biopharmaceuticals Ltd. Hemostatic composition
CN116212008A (zh) * 2023-03-15 2023-06-06 武汉康宁美生物科技有限公司 一种伤口创面消毒凝胶及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2532348A (en) * 1946-12-12 1950-12-05 Szent-Gyorgyi Albert Blood clotting preparation
CH303082A (de) * 1950-12-18 1954-11-15 Hoechst Ag Verfahren zur Herstellung eines haltbaren Thrombinpräparates von gesteigerter Wirksamkeit.

Also Published As

Publication number Publication date
EP0211629B1 (de) 1990-06-06
JPH0359045B2 (de) 1991-09-09
EP0211629A1 (de) 1987-02-25
JPS6259222A (ja) 1987-03-14
US4637815A (en) 1987-01-20
DE3671700D1 (de) 1990-07-12

Similar Documents

Publication Publication Date Title
ATE53299T1 (de) Blutstillende irrigationsloesung.
PT96103A (pt) Processo para a preparacao de proteinas fibrinoliticas e anti-tromboticas activaveis
DE3684680D1 (de) Peptidplasminogenaktivatoren.
HU9503312D0 (en) Modified factor vii
FR2588189B1 (fr) Composition pharmaceutique de type a transition de phase liquide-gel
ES2037669T3 (es) Un procedimiento para preparar una sustancia que se une a la trombina.
CY1110516T1 (el) Αναστρεψιμα απενεργοποιημενη οξινισμενη πλασμινη
DK76085D0 (da) Antiinflammatoriske forbindelser og farmaceutiske midler indeholdendeforbindelserne
ES2139740T3 (es) Cola de fibrina de dos componentes.
DK36991D0 (da) Vaevsplasminoaktivator-(t-pa)-variant med zymogene eller fibrinspecifikke eller plasmakoagel-specifikke egenskaber, fremgangsmaade til fremstilling deraf, dna-sekvens, som koder for varianten, replicerbar udtrykkelsesvektor for denne og vaertsceller transformeret med vektoren
ATE65185T1 (de) Thrombolytische zusammensetzung und verfahren zu deren herstellung.
ATE84222T1 (de) Gamma-ifn als wirkstoff zur hemmung (verhinderung) von abbauprozessen im knochen.
SE8701921D0 (sv) Ny farmaceutisk anvendning
FI924306A0 (fi) Foerbaettrat vaevnadslim som framstaellts genom anvaendning av kryofaellning.
DE69231401D1 (de) Herstellung von faktor-ix
ES8607734A1 (es) Procedimiento para producir un preparado farmaceutico desti-nado a aplicacion por via topica
ES2177646T3 (es) Procedimientos para el tratamiento de los trastornos hemorragicos.
DE59005355D1 (de) Dialysier- und Spüllösung zur intraperitonealen Verarbreichung.
ATE58521T1 (de) Lysinsalz der 4-biphenylessigsaeure und es enthaltende augenheilmittel.
DE3888619D1 (de) Modifizierter Gewebeplasminogenaktivator.
DE3780357D1 (de) Plasminogen-aktivator und thrombolytische zusammensetzung.
KR890701732A (ko) 개량형 조직 플라스미노겐 활성화 인자
RU2057534C1 (ru) Способ лечения трофических язв
EP0386240A4 (en) Novel polypeptide compounds
ES2033927T3 (es) Utilizacion de la forma farmaceutica de "gel" conteniendo acido n-(2,6-cicloro-m-tolil)-antranilico (acido meclofenamico) utilizable en terapia de uso topico.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee